Lexeo Therapeutics earnings were -$87.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest LXEO earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$25.9M, up 28.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LXEO reported annual earnings of -$100.0M, with 1.7% growth. The next LXEO earnings date is Nov 4, 2026.
What were Lexeo Therapeutics's earnings last quarter?
On LXEO's earnings call on Aug 13, 2026, Lexeo Therapeutics (NASDAQ: LXEO) reported Q2 2026 earnings per share (EPS) of -$0.30, up 50% year over year. Total LXEO earnings for the quarter were -$25.87 million. In the same quarter last year, Lexeo Therapeutics's earnings per share (EPS) was -$0.60.
The next LXEO earnings call is Nov 4, 2026. Add LXEO to your watchlist to be reminded of Lexeo Therapeutics's next earnings date.
Is Lexeo Therapeutics profitable or losing money?
As of the last Lexeo Therapeutics earnings report, Lexeo Therapeutics is currently losing money. Lexeo Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$87.27 million, a 23.57% decrease year over year.
What was LXEO's earnings growth in the past year?
As of Lexeo Therapeutics's earnings date in Aug 13, 2026, Lexeo Therapeutics's earnings has grown year over year. LXEO earnings in the past year totalled -$87.27 million.
What are Lexeo Therapeutics's earnings expectations?
The current EPS estimate for Lexeo Therapeutics's earnings report in Nov 4, 2026 is -$0.33.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.